DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
von Minckwitz G, Schneeweiss A, Loibl S. et al.
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.
Lancet Oncol 2014;
15: 747-756
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.